New cancer drug enters early human testing

NCT ID NCT06187402

Recruiting now Disease control Sponsor: LaNova Medicines Limited Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This early-phase trial is testing an experimental drug called LM-24C5 in about 49 people with advanced solid tumors that have not responded to standard treatments. The main goals are to check the drug's safety, find the best dose, and see if it shows any signs of shrinking tumors. Participants receive the drug intravenously, and the study is currently recruiting.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: LM-24C5 (an experimental drug given intravenously)
What this could lead to: If this works, it could point toward a new treatment option for people with advanced solid tumors that have not responded to other therapies.
What could go wrong: This is a very early, small trial (49 people) focused on safety and dosing. The drug may not shrink tumors or could cause side effects. Success is far from guaranteed.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ADVANCED SOLID TUMOR

Contacts and locations

Locations

Indiana University Melvan and Bren Simon Cancer Center
NOT_YET_RECRUITING

Indianapolis, Indiana, 46202, United States
Mary Crowley Cancer Research Center
NOT_YET_RECRUITING

Dallas, Texas, 75230, United States
Ocala Oncology
RECRUITING

Ocala, Florida, 34474, United States
The Christ Hospital
NOT_YET_RECRUITING

Cincinnati, Ohio, 45219, United States
University of Southern California (USC) - Norris Comprehensive Cancer Center
NOT_YET_RECRUITING

Los Angeles, California, 90089, United States
Virginia Cancer Specialists, P.C.
NOT_YET_RECRUITING

Fairfax, Virginia, 22031, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.